Aging of population results in an increasing number of patients with dementia. Therefore, recently a BMBF-supported project, Competence Net Dementia, was launched to reveal diagnostic, therapeutic, and epidemiologic aspects of demential disorders. In this project, our task was to establish and maintain human body fluids (HBF) bank to collect cerebrospinal fluid, plasma, serum, and full blood of patients enrolled into the study. As the pre-analytical sample handling is a prerequisite of all studies aiming at finding novel disease biomarkers, standard operating procedures (SOPs) were launched by our group to allow standardized collection, storage, and shipment of the samples among all 14 University centers involved in HBF collection. Currently, to our best knowledge the CND HBF bank represents one of the largest prospectively collected set of the samples from subjects with mild cognitive impairment and early dementias. With the samples collected in the HBF bank, recently introduced analytical technologies (like e.g. surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS), differential gel electrophoresis (DIGE™), and multiplexing) can be promptly tested with regard to their potential usefulness in neurochemical dementia diagnostics.
This is a preview of subscription content, log in via an institution to check access.
Access this article Subscribe and saveSpringer+ Basic
€34.99 /Month
Price includes VAT (Germany)
Instant access to the full article PDF.
Similar content being viewed by others Explore related subjectsDiscover the latest articles and news from researchers in related subjects, suggested using machine learning. ReferencesN Andreasen C Hesse P Davidsson L Minthon A Wallin B Winblad H Vanderstichele E Vanmechelen K Blennow (1999) ArticleTitleCerebrospinal fluid β-amyloid(1–42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease Arch Neurol 56 673–680 Occurrence Handle10369305 Occurrence Handle1:STN:280:DyaK1M3psF2kuw%3D%3D Occurrence Handle10.1001/archneur.56.6.673
N Andreasen L Minthon P Davidsson E Vanmechelen H Vanderstichele B Winblad K Blennow (2001) ArticleTitleEvaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice Arch Neurol 58 373–379 Occurrence Handle11255440 Occurrence Handle1:STN:280:DC%2BD3M7pvVCjuw%3D%3D Occurrence Handle10.1001/archneur.58.3.373
R Bullock (2002) ArticleTitleNew drugs for Alzheimer’s disease and other dementias Br J Psychiatry 180 135–139 Occurrence Handle11823323 Occurrence Handle10.1192/bjp.180.2.135
ER Frears DJ Stephens CE Walters H Davies BM Austen (1999) ArticleTitleThe role of cholesterol in the biosynthesis of β-amyloid Neuroreport 10 1699–1705 Occurrence Handle10501560 Occurrence Handle1:CAS:528:DyaK1MXksFaltb0%3D
NA Karp DP Kreil KS Lilley (2004) ArticleTitleDetermining a significant change in protein expression with DeCyder during a pair-wise comparison using two-dimensional difference gel electrophoresis Proteomics 4 1421–1432 Occurrence Handle15188411 Occurrence Handle1:CAS:528:DC%2BD2cXktFChsrk%3D Occurrence Handle10.1002/pmic.200300681
D Knopman (2001) ArticleTitlePharmacotheraphy for Alzheimer’s disease Curr Neurol Neurosci Rep 1 428–434 Occurrence Handle11898553 Occurrence Handle1:STN:280:DC%2BD387msleisQ%3D%3D
P Lewczuk H Esselmann M Meyer V Wollscheid M Neumann M Otto JM Maler E Rüther J Kornhuber J Wiltfang (2003) ArticleTitleThe amyloid-β (Aβ) peptide pattern in cerebrospinal fluid in Alzheimer’s disease: evidence of a novel carboxyterminally elongated Aβ peptide Rapid Commun Mass Spectrom 17 1291–1296 Occurrence Handle12811752 Occurrence Handle1:CAS:528:DC%2BD3sXltFalsL0%3D Occurrence Handle10.1002/rcm.1048
P Lewczuk H Esselmann TW Groemer M Bibl JM Maler P Steinacker M Otto J Kornhuber J Wiltfang (2004) ArticleTitleAmyloid β peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer’s disease Biol Psychiatry 55 524–530 Occurrence Handle15023581 Occurrence Handle1:CAS:528:DC%2BD2cXitFCiurk%3D Occurrence Handle10.1016/j.biopsych.2003.10.014
P Lewczuk G Beck H Esselmann R Bruckmoser R Zimmermann M Fiszer M Bibl JM Maler J Kornhuber J Wiltfang (2006) ArticleTitleEffect of sample collection tubes on CSF concentrations of Tau proteins and amyloid β peptides Clin Chem 52 332–334 Occurrence Handle16449222 Occurrence Handle1:CAS:528:DC%2BD28Xht1Krsrc%3D Occurrence Handle10.1373/clinchem.2005.058776
R Mayeux (1998) ArticleTitleEvaluation and use of diagnostic tests in Alzheimer’s disease Neurobiol Aging 19 139–143 Occurrence Handle9558150 Occurrence Handle1:STN:280:DyaK1c3hslagsQ%3D%3D Occurrence Handle10.1016/S0197-4580(98)00014-1
M Merchant SR Weinberger (2000) ArticleTitleRecent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry Electrophoresis 21 1164–1177 Occurrence Handle10786889 Occurrence Handle1:CAS:528:DC%2BD3cXis12ku7g%3D Occurrence Handle10.1002/(SICI)1522-2683(20000401)21:6<1164::AID-ELPS1164>3.0.CO;2-0
A Olsson H Vanderstichele N Andreasen G De Meyer A Wallin B Holmberg L Rosengren E Vanmechelen K Blennow (2005) ArticleTitleSimultaneous measurement of beta-amyloid(1–42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology Clin Chem 51 336–345 Occurrence Handle15563479 Occurrence Handle1:CAS:528:DC%2BD2MXhtVGhu7k%3D Occurrence Handle10.1373/clinchem.2004.039347
InstitutionalAuthorNameThe Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” (1998) ArticleTitleConsensus report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”. The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association and the National Institute on Aging Working Group Neurobiol Aging 19 109–116 Occurrence Handle10.1016/S0197-4580(98)00022-0
DA Vignali (2000) ArticleTitleMultiplexed particle-based flow cytometric assays J Immunol Methods 243 243–255 Occurrence Handle10986418 Occurrence Handle1:CAS:528:DC%2BD3cXmtlGksr8%3D Occurrence Handle10.1016/S0022-1759(00)00238-6
Department of Psychiatry and Psychotherapy, University of Erlangen-Nuremberg, Germany
P. Lewczuk, J. Kornhuber & J. Wiltfang
Center for Clinical Neuroproteomics, Erlangen, Germany
P. Lewczuk, J. Kornhuber & J. Wiltfang
Lewczuk, P., Kornhuber, J. & Wiltfang, J. The German Competence Net Dementias: Standard operating procedures for the neurochemical dementia diagnostics. J Neural Transm 113, 1075–1080 (2006). https://doi.org/10.1007/s00702-006-0511-9
Received: 25 September 2005
Accepted: 05 April 2006
Published: 13 July 2006
Issue Date: August 2006
DOI: https://doi.org/10.1007/s00702-006-0511-9
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4